Archiv: Ingmar Hoerr


16.03.2020 - 15:10 [ labiotech.eu ]

Battle of the Biotech Unicorns: CureVac vs. Moderna

(06.11.2017)

But despite being competitors, the companies’ CEOs seem to have quite a good relationship and consider each other collaborators rather than enemies. Every year, they organize an mRNA conference together that takes turns between Boston and Berlin to bring together all the stakeholders in the field. It was at this year’s edition, in Berlin, that I had the chance to bring them together for an interview regarding the future of mRNA therapies.

15.03.2020 - 17:33 [ biopharmadive.com ]

CureVac CEO replaced in midst of biotech’s coronavirus push

(12.03.2020)

Last Monday, Menichella was among the top executives of nearly a dozen biotech and pharmaceutical companies briefing President Trump on their respective coronavirus drug development plans. Just over a week later, he was out as CEO, replaced by CureVac founder and former CEO Hoerr.

It’s a rapid transition in leadership at a time when the company is in the global spotlight for its efforts to quickly advance a coronavirus vaccine into human testing.